Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
The tiniest patients face the biggest odds when it comes to acute lymphoblastic leukemia. St. Jude clinicians and researchers work to change that scenario.
Scientists at St. Jude Children’s Research Hospital who represent the interdisciplinary team studying acute lymphoblastic leukemia (ALL) have been recognized by the American Association for Cancer Research (AACR) with the AACR Team Science Award.
Accelerated approval of the drug clofarabine to treat relapsed or refractory pediatric acute lymphoblastic leukemia (ALL) shows the importance of offering children rapid access to new treatments through clinical trials, said investigators at St. Jude.
Data from a clinical trial led by investigators at St. Jude Children's Research Hospital with the investigational agent clofarabine were presented June 5 at the 40th annual meeting of the American Society of Clinical Oncology.